Wada N, Murakami T, Fauzi M, Sakaki K, Oshima S, Shimada Y, et al. Elevated Serum Growth Differentiation Factor 15 Levels as a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study. J Clin Med Res [Internet]. 2024 Oct. 31 [cited 2024 Nov. 21];16(10):503-8. Available from: https://jocmr.elmerjournals.com/jocmr/article/view/6031